Parkinsons disease PD is a progressive neurodegenerative disorder caused by the neuronal death in the substantia nigra (SN), degeneration of dopaminergic neurotransmission, and the presence of -synuclein and protein inclusions in neuronal cell bodies (Lewy bodies) [4-5,7]
Patients often describe ropey tissue over the tendonthis is a palpable marker of degenerative change and a guideline for targeted peritendinous treatment
References: PubChem Database BPC-157 (CHNO) National Center for Biotechnology Information (NCBI) Studies on BPC-157 and tissue repair Journal of Drug Targeting Effects of BPC-157 on Angiogenesis and Organ Regeneration You can also use our peptide calculator to convert mg to mL and syringe units based on your dilution
Patients who want antioxidant support alongside GLP-1 therapy can take both
however, the former is more common
Clean label, vegan, 3rd party tested